Sanwa Kagaku Kenkyusho Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceuticals, diagnostics, medical and nursing care nutritionals, and healthcare products. The company also provides contract manufacturing services for pharmaceuticals. It offers products through a network of medical representatives worldwide. The company was founded in 1953 and is based in Nagoya, Japan. Sanwa Kagaku Kenkyusho Co., Ltd. operates as a subsidiary of Suzuken Co., Ltd.

Since 1955, WAKUNAGA’s mission statement is “they serve the public’s health from the entrepreneur spirit and contribute to the society through the development of outstanding products by using the unique technology” . WAKUNAGA has been moving forward in developing reliable healthcare products to maintain your health.

The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.

Guangzhou Wuliang Biotechnology Co., Ltd., established on 2014-08-11, Business scope includes biological control technology development services;Biological Control Technology Consulting,communication service;insect farming;Technology Import and Export;Biotechnology Extension Services;feed retail;feed wholesale;Biomass densified briquette fuel sales;Commodity retail trade(Except for licensed and approved products);Commodity wholesale trade(Except for licensed and approved products);Import and export(Excluding franchised products);

ES Corp is a private company headquartered in the United States, also operating in the United States. The firm acquires various companies.

Shaoxing Jiuyue Intelligent Equipment Co., Ltd., established on 2020-05-27, Business scope includes general items:Industrial automatic control system device sales;Manufacturing of industrial control computers and systems;Intelligent basic manufacturing equipment manufacturing;Intelligent robot sales;Industrial Robot Sales;Research and development of intelligent robots;Sales of Service Consumer Robots;AI Hardware Sales;General Equipment Repair;Mechanical equipment research and development;Machinery and Equipment Leasing;Sales of electrical machinery and equipment;Machinery sales;General machinery and equipment installation services;Intelligent storage equipment sales;Artificial intelligence application software development;Wearable smart device sales;Computer and Office Equipment Repair;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;Sales of industrial control computers and systems;Computer System Services;software sales;Information security equipment sales;Digital Video Surveillance System Sales;Network Equipment Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA.

Guangzhou Tianwei Biotechnology Co., Ltd., established on 2009-05-18, Business scope includes fresh poultry wholesale;vegetable wholesale;Vegetable acquisition;Sell ​​saplings(Except those prohibited by laws and regulations);Acquisition of agricultural and sideline products;Fertilizer Wholesale;Wholesale of Organic Fertilizers and Microbial Fertilizers;Import and export(Excluding franchised products);Technology Import and Export;Sales of plant extract raw materials(Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);Fresh Meat Wholesale(pig only,Cattle,mutton);feed retail;Feed Additives Retail;feed wholesale;Feed Additives Wholesale;Manufacture of organic fertilizers and microbial fertilizers;Sale of packaged seeds that are no longer subpackaged;vegetable retail;poultry slaughter;Processing of plant extract raw materials(Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);Manufacturing of organic chemical raw materials(Monitor Chemicals,Excluding hazardous chemicals);Manufacturing of other non-hazardous basic chemical raw materials;Other warehousing(Does not contain crude oil,Refined oil storage,Gas Storage,Dangerous goods storage);Manufacture of water treatment agents for aquaculture(Monitor Chemicals,Excluding hazardous chemicals);Fresh Poultry Retail;Primary processing service of agricultural products;Other Meat Retail(pig,Cattle,except mutton);Planting of other cash crops;Agricultural Technology Development Services;gas,Liquid separation and purification equipment manufacturing;Feed additives,Additive premix feed production;feed processing

Biosource Biotechnology (Shenzhen) Co., Ltd., established on 2000-08-02, Business scope includes general business items:Bio-feed R&D;Feed Additive Sales;Feed Raw Material Sales;Food Additive Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Feed additive production;feed production;animal husbandry;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”